Camillo Autore | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases	JOURNAL OF CARDIOVASCULAR MEDICINE	2025
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology	JOURNAL OF CARDIOVASCULAR MEDICINE	2025
Cardiological Manifestations in Males and Females Affected by NAA10‐Related Disease	AMERICAN JOURNAL OF MEDICAL GENETICS. PART A	2025
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy	JACC. ADVANCES	2025
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis	MAYO CLINIC PROCEEDINGS	2025
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patients	EUROPEAN JOURNAL OF HUMAN GENETICS	2025
Monitoring the Effects of Cardiac Rehabilitation Programs in Heart Failure Patients: The Role of Biomarkers	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology	JOURNAL OF CARDIOVASCULAR MEDICINE	2025
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes	INTERNATIONAL JOURNAL OF CARDIOLOGY	2024
Position statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on cardiac rehabilitation and protection programs as a cornerstone of secondary prevention after myocardial infarction or revascularization	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis	JACC. ADVANCES	2024
Re-analysis of Next-generation Sequencing Data in Patients with Hypertrophic Cardiomyopathy: Contribution of Spliceogenic MYBPC3 Variants in an Italian Cohort	ANNALS OF LABORATORY MEDICINE	2024
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis	JACC. ADVANCES	2024
Arrhythmic risk stratification in patients with left ventricular ring-like scar	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2024
Arrhythmic Stratification of Cardiac Amyloidosis: State of the Art	HEART FAILURE CLINICS	2024
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy	CURRENT ISSUES IN MOLECULAR BIOLOGY	2023
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Risk stratification in transthyretin-related cardiac amyloidosis	FRONTIERS IN CARDIOVASCULAR MEDICINE	2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study	EUROPEAN JOURNAL OF HEART FAILURE	2023
Diagnostic Delay in Arrhythmogenic Cardiomyopathy	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2023